The verified answer
As of Aug 2026, DEPLOY verifies SS Innovations International: 1 model, 1 deployment across 1 region. 2 sources back the record.
SS Innovations International has 1 FDA 510(k) clearance pending, per the DEPLOY registry.
See all 1 filingsCategorySurgical robots
Overview
US-based medical technology company (Nasdaq: SSII) developing the SSi Mantra multi-specialty surgical robotic system. Founded by Dr. Sudhir Srivastava, a globally acclaimed robotic cardiac surgeon, the company aims to make robotic surgery more affordable and accessible globally. The SSi Mantra 3 system covers general, urological, colorectal, gynecological, and cardiac surgical indications, and the company submitted its FDA 510(k) filing in late 2025.
Verified record
- Verified deployments
- 1 deployment on file
- Active incidents
- None on file
Key facts
Systems installed
Procedures performed
FDA status
CEO
Product
Funding raisedsee investors →
Data & sources
Web sources
2
2 sources backing this record.View all →
Models (1)
View all models →SS Innovations International on the deployment map
View the global map1 verified deployment across 1 region. Explore where SS Innovations International's robots are operating, by place and type.
View the full SS Innovations International deployment record →
Relationships
Current leadership (1)
- Sudhir Srivastava Founder, Chairman & CEOreported, not verified
Founders (1)
- Sudhir Srivastavacofounder
Safety record
No incidents on record for SS Innovations International.
Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.
Full safety record: incidents, sourcing, and exposure data →
Operator customers (1)
- SS Innovations International1 deployment
Recent coverage
SS Innovations International in third-party press
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Financial state
- Reporting basis
- private_reported
- Lifecycle stage
- growth
- Counterparty risk class
- moderate
Each numeric field carries its own basis marker. Aggregators report a number; this surface preserves the source class so verification depth travels with the value.
Regulatory filings (1)
- fda_510kfda 510k · us_fdapending2025-12-08
Linked models: SSi Mantra
Recent activity
Every change to this record is dated, sourced, and independently verified where marked.
- Record createdJul 2, 2026
Added to the verified registry
- Deployment verifiedVerifiedDec 1, 2024
SSi Mantra at Noble Hospitals and Research Centre
- Deployment verifiedVerifiedJan 1, 2024
SSi Mantra at Apex Hospital
- Deployment verifiedVerifiedJan 1, 2024
SSi Mantra at Continental Hospital
- Deployment verifiedVerifiedJan 1, 2023
SSi Mantra at Bengaluru, Karnataka, India
Sources (2)
Common questions
What is SS Innovations International?
What does SS Innovations International make?
Is SS Innovations International publicly traded?
Who competes with SS Innovations International?
Who is the CEO of SS Innovations International?
How can I invest in SS Innovations International?
Where is SS Innovations International headquartered?
Who owns SS Innovations International?
Where does SS Innovations International operate robots?
How many robots has SS Innovations International deployed?
Is SS Innovations International a top robotics company?
Is SS Innovations International safe?
Methodology: Verified · 2 sources (no primary) · last reviewed 2026-08-05
Verification posture
Verified
Low confidence
Review state
Stable
Last reviewed 2026-08-05
Sources by quality tier
- 2
- unclassified
- Unclassified source
The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.
Methodology surface for SS Innovations International.Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
In the press
Recent coverage mentioning SS Innovations International from third-party publications. Automatically surfaced; not part of the verified registry record.
UC Berkeley to Join Applied Materials’ EPIC Center to Speed Chip Innovation
Applied Materials, announced that the University of California, Berkeley will join the company’s EPIC Center in Silicon Valley as a research collaborator. Working side by side…
SS Innovations raises 8.6M ahead of US surgical robot launch
SS Innovations raised 8.6M from investors including Dr. Sudhir Srivastava and Dr. Fred Moll ahead of the US launch of its SSi Mantra surgical robot.
SS Innovations submits robotic system for FDA clearance
SS Innovations submitted its 510(k) premarket notification to the FDA for the SSi Mantra surgical robotic system, seeking clearance for general, urological, colorectal,…
How SS Innovations is expanding robotic surgery's reach
MedTech Dive profiles SS Innovations and founder Dr. Sudhir Srivastava's mission to make robotic surgery affordable and accessible globally with the SSi Mantra system.
Machine-readable surfaces
- Markdown mirror: /companies/ss-innovations.md
- RSS feed: /companies/ss-innovations/feed.xml
- JSON-LD: embedded in this page’s head
- REST API: /v1/companies/d379bc4f-a144-46c8-8c2a-17554ab559e1
- Revision history: /companies/ss-innovations/history
- Data documentation: /data
- Query this programmatically: Deploy MCP
Peer companies
- Brainlab2 models
- EndoQuest Robotics2 models
- Intuitive Surgical2 models
- LEM Surgical2 models
- MicroPort MedBot2 models
- Neocis2 models
Video
IERCSC 2026 brought together leading cardiac surgeons, educators, and innovators from across the world for two days dedicated to advancing the future of robotic
The honeymoon phase for shiny healthcare tech is over. We are staring down real legislative mandates and the hard reality of workflow adoption. I walked the fl
Experience the Future of Robotic Cardiac Surgery at IERCSC 2026 International Endoscopic & Robotic Cardiac Surgery Conference (IERCSC 2026) witnessed leading ca
Reality vs attention
SS Innovations International draws attention at the 31st percentile but verifies reality at the 85th percentile among surgical robots. Hype Gap -54.1, 36th widest among surgical robots.
6-month trend
Analysis
Clean safety record across 6 verified deployments. Strong deployment footprint with 6 operational sites across 6 countries. Limited public funding data for capital position assessment.
Signal flags
Dimension breakdown
Verified signal
Attention (reach, not merit)
DEPLOY Intelligence scores are computed from verified registry data: confirmed deployments, disclosed funding rounds, regulatory filings, active job listings, video viewership, and press coverage. Confidence ratings reflect data availability. Scores update nightly.
DEPLOY Indices — verified vs claimed
Last computed: Aug 18, 2026